Damien Hirst The Cure For Sale

Damien Hirst: The Cure Series

Market-Leading Editions from Contemporary Art's Most Provocative Voice

Damien Hirst's position within the contemporary art market remains singular and defining. The artist whose "Beautiful Inside My Head Forever" sale generated $198 million at Sotheby's in 2008—an unprecedented single-artist auction that rewrote market expectations—continues to command serious collector attention across all mediums. With Lullaby Spring achieving $19.2 million at Sotheby's in 2007 and the Art Basel & UBS Global Art Market Report confirming the market's return to growth in 2025 following a $57.5 billion global valuation in 2024, Hirst's strategic editions present compelling acquisition opportunities. Guy Hepner in New York, having facilitated $4,226,125 in Damien Hirst transactions, offers specialized access to The Cure series—a refined body of silkscreen works that distills the artist's pharmaceutical iconography into vibrant, collectible formats.

Series Context: Medicine, Mortality, and the Aesthetic of Remedy

The Cure series, created in 2014, represents Hirst's continued interrogation of humanity's complex relationship with pharmaceuticals, healing, and the promises embedded in modern medicine. These works emerge from the same conceptual territory that produced his iconic Medicine Cabinets and Pharmacy installations—pieces that positioned the artist as contemporary art's foremost commentator on our collective faith in chemical intervention.

Where earlier pharmaceutical works employed actual pill bottles and clinical display cases, The Cure abstracts this investigation into pure chromatic experience. Each composition presents enlarged capsule forms rendered in carefully calibrated color combinations, transforming mundane objects of medical consumption into monuments of visual seduction. The series title itself carries deliberate ambiguity: "the cure" suggests both remedy and the impossibility of ultimate healing, reflecting Hirst's persistent engagement with mortality themes that have defined his practice since the Young British Artists movement elevated him to international prominence in the 1990s.

As the leading figure of the YBA generation, Hirst brought conceptual rigor and commercial savvy into unprecedented alignment. White Cube's ongoing representation and Science Ltd's authentication protocols ensure market confidence, while the artist's strategic approach to editioning has created distinct collector pathways across price points.

Technical Specifications: Precision and Material Excellence

The Cure silkscreens demonstrate exceptional production values consistent with Hirst's exacting standards. Executed on Somerset Tub Sized 410gsm paper, these works utilize a substrate renowned among printmakers for its archival stability, tactile presence, and capacity to hold saturated color without bleeding or degradation.

The silkscreen process—chosen deliberately over digital printing methods—connects these works to the legacy of Warhol and the Pop tradition Hirst both references and extends. Each impression requires multiple passes through the press, with successive color layers building the dimensional quality that distinguishes fine art printmaking from mechanical reproduction. The Somerset paper's substantial weight contributes physical gravitas appropriate to the pharmaceutical monumentality Hirst constructs.

Color selection across the series reveals systematic thinking. Pairings range from clinical and institutional—Battleship Grey against Fizzy Orange—to deliberately synthetic combinations suggesting laboratory creation rather than natural occurrence. This chromatic vocabulary reinforces conceptual content: these are manufactured hues for manufactured remedies.

Notable Works: Chromatic Variations and Collector Considerations

The Cure (Mint Blue/Apple Green/Lemon Yellow) presents perhaps the series' most optically active combination, with cool and warm tones creating visual vibration characteristic of color field investigations. The mint blue ground provides clinical coolness while citrus accents inject synthetic vitality.

The Cure (Fire Red/Sun Yellow/Fire Orange) operates at maximum chromatic intensity, its warm spectrum suggesting both warning and attraction—the seductive danger Hirst consistently locates in pharmaceutical promise.

The Cure (Violet/Electric Red/Powder Blue) demonstrates the artist's facility with unexpected harmonies, combining regal violet with aggressive red and calming blue in configurations that shouldn't cohere yet achieve striking balance.

The Cure (Vivid Blue/Cloudy Pink/Candy Floss Pink) offers softer tonalities, its confectionary palette suggesting the sugar-coating of difficult medical realities—literal and metaphorical.

The Cure (Battleship Grey/Fizzy Orange/Berry) and The Cure (Bright Orange/Orchid/Air Force Blue) both executed on Somerset Tub Sized 410gsm, anchor the series with institutional undertones complicated by unexpected chromatic interventions.

Investment Analysis: Edition Strategy and Market Position

Hirst's print market benefits from infrastructure unavailable to most contemporary artists. Science Ltd authentication provides definitive provenance verification, eliminating attribution uncertainties that complicate secondary market transactions. This institutional backing, combined with White Cube representation, establishes confidence essential for serious collectors building positions.

The 2014 creation date positions The Cure series within Hirst's mature practice, following the market validation of major auction results while preceding recent conceptual departures. This timing offers collectors works produced during peak institutional recognition while remaining accessible relative to unique pharmaceutical pieces commanding seven and eight-figure results at Christie's, Sotheby's, and Phillips.

Edition formats create natural price stratification, allowing entry-level acquisition with potential for strategic upgrading as collector sophistication and resources develop. The series' coherent thematic structure enables focused collecting—multiple works can be assembled without redundancy, each color combination offering distinct aesthetic experience within unified conceptual framework.

With global market recovery confirmed by Art Basel & UBS reporting, established contemporary names demonstrating consistent auction performance present reduced acquisition risk compared to emerging positions.

Acquisition Through Guy Hepner

Guy Hepner in New York maintains specialized expertise in Damien Hirst editions, with transaction volume exceeding $4.2 million demonstrating sustained collector confidence. Our position within Hirst's distribution network enables access to premium examples with verified provenance and condition.

Prospective collectors are invited to contact Guy Hepner for current availability across The Cure series, detailed condition reporting, and strategic guidance on building Hirst positions aligned with individual collection objectives.